Measuring the Impact of Patient Engagement Activities in Medicines R&D

DIA members: Sign in below to see content options. Not a member? Enjoy this preview, then see below to join DIA today!

Read Full Transcript     Watch Interactive Transcript     Listen and Download


Key Takeaways

  • Patient engagement initiatives are shown to increase chances of regulatory approval and accelerate development timelines.
  • Metrics for assessing the value and impact of patient engagement initiatives are non-existent, inconsistently applied, or fail to provide actionable information.
  • Relatively easy, low-cost patient engagement initiatives, such as advisory boards, panels, and focus groups, often make a larger impact compared to other, more complex or costly activities.
  • Many organizations don’t have a streamlined patient engagement function, with activities instead taking place in multiple functions within one company.

Member Benefits

  • Full Video, Transcript and Audio-only Version Available

See All Insider Access Videos


This content is for DIA Members only. JOIN NOW for full access!